%0 Journal Article
%T Chemotherapy for breast cancer progresses to liver metastases after surgery and systemic treatment
%A Baozhen Liu
%A Chenggang Luo
%A Dongde Wu
%A Jianjun Liang
%A Lei Nie
%A Tao Yin
%A Xinhong Wu
%A Yaojun Feng
%J SCIE-indexed Journal
%D 2020
%R 10.21037/tcr.2019.12.59
%X Approximately 50% of patients with metastatic breast cancer will have liver involvement at some point during the course of their disease, and 5¨C12% of patients with metastatic breast cancer will have liver involvement (1-3). In these patients, unresectable breast cancer liver metastasis (UBCLM) is a major cause of mortality, and this is associated with poor prognosis. Breast cancer is the second leading cause of cancer-related death among women in the United States, with an estimated 39,840 deaths from breast cancer in 2010 (4)
%U http://tcr.amegroups.com/article/view/34987/html